New evidence for how blood clots may form in very ill COVID-19 patients

Cold Spring Harbor Laboratory
30-Jun-2020 12:15 PM EDT, by Cold Spring Harbor Laboratory

Newswise — Scientists have new evidence that overactive neutrophils--a common type of circulating immune cell--may drive the life-threatening blood clots and inflammation that occur in some patients with COVID-19. High levels of the sticky, pathogen-trapping webs produced by the cells were associated with the most severe cases of COVID-19 in a study reported online in the journal Blood.

Neutrophil extracellular traps (NETs) are a type of defense that the immune system deploys against certain pathogens--webs of DNA and toxins that ensnare and destroy viruses and bacteria. When too many of these NETs accumulate during a persistent infection, they can lead to acute respiratory distress syndrome, which leads many patients with COVID-19 to require intensive care.

Researchers at Cold Spring Harbor Laboratory (CSHL), University of Utah Health, PEEL Therapeutics and Weill Cornell Medicine collaborated to investigate NETs suspected role in COVID-19, collecting blood samples from 33 hospitalized patients, as well as autopsy tissue. They found that biomarkers of NET formation were more abundant in patients who required ventilation, and highest in the three study participants who eventually died from COVID-19.

When the team examined the lungs of the patients who died, they found tiny clots of tangled NETs and blood platelets known as microthrombi scattered through the tissue. "It will be important to investigate NETs role in clot formation (thrombosis) not only in light of the COVID-19 pandemic, but also to understand their broader role in disease," says CSHL Associate Professor Mikala Egeblad.

"Excess NETs are formed in other viral diseases," she says. "We also know that clotting is a major cause of death in people with end-stage cancer, so what we are learning in COVID-19 may help us understand basic properties in cancer and other diseases."

In the laboratory, neutrophils from patients with COVID-19 churned out exceptionally high levels of NETs, and the researchers found healthy neutrophils behaved the same way when they were exposed to plasma from patients with the illness. They could stop NET production, however, by exposing cells to neonatal NET-Inhibitory Factor (nNIF), an anti-inflammatory peptide from umbilical cord blood that protects newborn babies.

Several therapeutic strategies for dismantling NETs or preventing their formation are currently under investigation. These include the nNIF peptide, which is in pre-clinical development by PEEL Therapeutics. "Although further studies will be required, the NET-inhibitory protein may block exaggerated NET formation in COVID-19 patients," says Christian Con Yost, whose laboratory at University of Utah Health discovered nNIF in 2016.

###

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 2911
Newswise: Obesity a Major Risk for Severe COVID-19 Cases
Released: 13-Aug-2020 4:55 PM EDT
Obesity a Major Risk for Severe COVID-19 Cases
Hackensack Meridian Health

While the U.S. Centers for Disease Control and Prevention (CDC) advises that people of any age can contract COVID-19, obesity has emerged among the major risk factors for severe cases. With more than 40 percent of Americans classified as obese, experts caution that this is a growing concern.

Newswise: Ophthalmologists Anticipate a School Year Marked by Complaints of Eye Strain
Released: 13-Aug-2020 4:10 PM EDT
Ophthalmologists Anticipate a School Year Marked by Complaints of Eye Strain
American Academy of Ophthalmology (AAO)

The American Academy of Ophthalmology shares back-to-online school checklist to protect kids’ eyes from too much screen time.

Newswise: 240042_web.jpg
Released: 13-Aug-2020 3:05 PM EDT
A quick, cost-effective method to track the spread of COVID-19
Hokkaido University

A group of researchers have demonstrated that, from seven methods commonly used to test for viruses in untreated wastewater, an adsorption-extraction technique can most efficiently detect SARS-CoV-2. This gives us another tool to detect the presence and spread of the COVID-19 pandemic.

Released: 13-Aug-2020 2:40 PM EDT
Technion’s Nanofiber PPE Sticker Now In Mass Production
American Technion Society

The COVID-busting ‘Maya’ sticker developed by Technion researchers has gone into mass production. Comprised of a nanofiber sheet, the unique sticker can be easily adhered to a protective mask, significantly improving its effectiveness against the novel coronavirus.

13-Aug-2020 11:00 AM EDT
Massive, rapid vaccine production will require firms to share information
University of Michigan

As the world rushes to identify safe and effective vaccines and therapeutics to counter the COVID-19 epidemic, attention is turning to the next step: manufacturing these products at enormous scale.

Released: 13-Aug-2020 1:05 PM EDT
Additive Manufacturing for COVID-19
Materials Research Society (MRS)

A new Prospective article—Additive Manufacturing for COVID-19: Devices, Materials, Prospects and Challenges—published in MRS Communications, looks at these critical supply issues and provides an overview of 3D printing and how coupling the tools in additive manufacturing (AM) and advanced materials has provided a viable alternative for rapid production and distribution of PPEs and medical devices.

Newswise: Busting Up the Infection Cycle of Hepatitis B
Released: 13-Aug-2020 12:50 PM EDT
Busting Up the Infection Cycle of Hepatitis B
University of Delaware

Researchers at the University of Delaware have gained new understanding of the virus that causes hepatitis B and the “spiky ball” that encloses the virus’s genetic blueprint. They examined how the capsid—a protein shell that protects the blueprint and also drives the delivery of it to infect a host cell—assembles itself. Scientists believe that the capsid is an important target in developing drugs to treat hepatitis B, a life-threatening and incurable infection that afflicts more than 250 million people worldwide.

Newswise: 240097_web.jpg
Released: 13-Aug-2020 12:05 PM EDT
Stay-at-home orders significantly associated with reduced spread of COVID-19, study finds
Brown University

Across the globe, COVID-19 has infected more than 18 million people to date and has killed hundreds of thousands -- and the United States has been hit especially hard.

Released: 13-Aug-2020 11:45 AM EDT
COVID-19 Symptom Tracker Ensures Privacy During Isolation
Georgetown University Medical Center

An online COVID-19 symptom tracking tool developed by researchers at Georgetown University Medical Center ensures a person’s confidentiality while being able to actively monitor their symptoms. The tool is not proprietary and can be used by entities that are not able to develop their own tracking systems.

Newswise: Support for telehealth and mobile health monitoring rises since COVID, study says
Released: 13-Aug-2020 11:25 AM EDT
Support for telehealth and mobile health monitoring rises since COVID, study says
University of Alabama Huntsville

Support for telehealth and mobile health monitoring has risen among healthcare workers and consumers since the rise of the COVID-19 pandemic, according to a new study. Dr. Emil Jovanov, a pioneer in the wearable health monitoring field from The University of Alabama in Huntsville (UAH), participated and was a coauthor.


Showing results

110 of 2911

close
1.76859